Arcus Biosciences, Inc.

RCUS

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001724521

SEC filings (opens in a new tab)

In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Arcus Biosciences, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of RCUS: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	186	1	190	+5
Shares	99.7M	11.0K	100.6M	+903.6K (+0.9%)
Value	$811.5M	$89.4K	$1.37B	+$556.8M (+68.6%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Arcus Biosciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to RCUS in Q3 2025
Institution	Shares	Value	% of portfolio
Candriam Luxembourg S.C.A.	378,441	$5.15M	0.03%
Standard Life Aberdeen plc	331,671	$4.42M	0.01%
Vestal Point Capital, LP	250,000	$3.40M	0.15%
Arrowstreet Capital, Limited Partnership	239,420	$3.26M	0.00%
AXA Investment Managers S.A.	232,668	$3.16M	0.01%
Adage Capital Partners GP, L.L.C.	152,000	$2.07M	0.00%
Winton Group Ltd	92,229	$1.25M	0.05%
HRT Financial LP	89,997	$1.22M	0.00%
Connor, Clark & Lunn Investment Management Ltd.	86,058	$1.17M	0.00%
Acadian Asset Management LLC	32,358	$438.0K	0.00%
Public Employees Retirement System of Ohio	22,000	$299.2K	0.00%
Quantinno Capital Management LP	15,211	$206.9K	0.00%
ISAM Funds (UK) Ltd	13,959	$189.8K	0.04%
Abich Financial Wealth Management LLC	5,096	$69.3K	0.02%
Rockefeller Capital Management L.P.	3,856	$52.4K	0.00%
SRS Capital Advisors, Inc.	1,386	$18.9K	0.00%
Quadrant Capital Group LLC	1,079	$14.7K	0.00%
Salomon & Ludwin, LLC	798	$10.7K	0.00%
Optiver Holding B.V.	672	$9.14K	0.00%
Aster Capital Management (DIFC) Ltd	234	$3.18K	0.00%
Halbert Hargrove Global Advisors, LLC	180	$2.45K	0.00%
Farther Finance Advisors, LLC	171	$2.33K	0.00%
Wealthspire Advisors, LLC	126	$1.71K	0.00%
Cedar Mountain Advisors, LLC	22	$299	0.00%
Allworth Financial LP	4	$55	0.00%
Advisory Services Network, LLC	3	$41	0.00%
Tortoise Investment Management, LLC	3	$41	0.00%
TFC Financial Management	1	$14	0.00%
Smartleaf Asset Management LLC	1	$13	0.00%

Sold out (24)

Institutions that held Arcus Biosciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of RCUS in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Integral Health Asset Management, LLC	300,000	$2.44M
AXA S.A.	231,978	$1.89M
Cubist Systematic Strategies, LLC	226,337	$1.84M
Squarepoint Ops LLC	199,649	$1.63M
Ikarian Capital, LLC	163,363	$1.33M
Walleye Capital LLC	126,259	$1.03M
Gsa Capital Partners LLP	116,461	$948.0K
Boothbay Fund Management, LLC	99,457	$809.6K
Qube Research & Technologies Ltd	84,049	$684.2K
UBS Oconnor LLC	52,975	$431.2K
XTX Topco Ltd	35,998	$293.0K
Maryland State Retirement & Pension System	20,202	$164.4K
Y-Intercept (Hong Kong) Ltd	16,794	$136.7K
Nomura Holdings Inc	15,603	$127.0K
Engineers Gate Manager LP	13,540	$110.2K
DRW Securities, LLC	13,285	$108.1K
Point72 (DIFC) Ltd	12,796	$104.2K
Bank of Montreal	11,304	$92.0K
PEAK6 LLC	10,000	$81.4K
Point72 Hong Kong Ltd	7,991	$65.0K
Caitong International Asset Management Co., Ltd	417	$3.39K
Skopos Labs, Inc.	362	$2.95K
MAI Capital Management	242	$1.97K
Fortitude Family Office, LLC	60	$488

Not filed for Q3 2025 yet (1)

Institutions that held Arcus Biosciences, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCUS in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
E Fund Management Co., Ltd.	10,987	$89.4K